CULLEN/FROST BANKERS, INC. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 140 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
CULLEN/FROST BANKERS, INC. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$20,000
+17.6%
4,4000.0%0.00%
Q3 2020$17,000
-19.0%
4,4000.0%0.00%
-100.0%
Q2 2020$21,0004,4000.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$144,839,00011.40%
Eversept Partners, LP 4,755,480$32,004,3802.41%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$109,116,0001.27%
EAM Global Investors LLC 365,719$2,461,0000.68%
Signature Wealth Management Partners, LLC 87,666$590,0000.57%
Jackson Creek Investment Advisors LLC 221,043$1,488,0000.52%
Tranquilli Financial Advisor LLC 71,414$481,0000.39%
Hillsdale Investment Management Inc. 611,200$4,113,0000.34%
EAM Investors, LLC 259,873$1,749,0000.26%
HUSSMAN STRATEGIC ADVISORS, INC. 180,000$1,211,0000.25%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders